Browsing byAuthorAwasthi, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 18 to 37 of 59< previous   next >
Issue DateTitleAuthor(s)
2017-12-01Formation of struvite urinary stones and approaches towards the inhibition—A reviewDas, P; Gupta, G; Velu, V; Awasthi, R; Dua, K; Malipeddi, H
2018-01Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.Samvedna, S; Jindal, S; Mishra, G; Madan, JR; Gupta, G; Awasthi, R; Pinto, TDJA; Dua, K; Kulkarni, GT
2016-06-01Formulation and evaluation of controlled release ethylcellulose and polyethylene glycol microspheres containing metoprolol tartrate.Malipeddi, VR; Awasthi, R; Dua, K
2017-07Formulation and evaluation of controlled-release matrix systems of ciprofloxacin.Malipeddi, VR; Awasthi, R; Dua, K
2021-02-16Formulation and evaluation of nano structured lipid carriers for intranasal delivery of buspirone hydrochlorideMathure, D; Madan, JR; Ranpise, HA; Awasthi, R; Dua, K; Gujar, KN
2019-01-01Formulation and evaluation of solid self-microemulsifying drug delivery system for azilsartan medoxomilMadan, JR; Patil, K; Awasthi, R; Dua, K
2020-07Formulation and In Vitro Evaluation of Casein Nanoparticles as Carrier for Celecoxib.Madan, JR; Ansari, IN; Dua, K; Awasthi, R
2018-07Formulation and solid state characterization of carboxylic acid-based co-crystals of tinidazole: An approach to enhance solubility.Madan, JR; Dagade, RH; Awasthi, R; Dua, K
2017-08-01Formulation, characterization and in-vitro evaluation of fast dissolving tablets containing gliclazide hydrotropic solid dispersionsMadan, JR; Kamate, VJ; Awasthi, R; Dua, K
2020-01-01Formulation, optimization, and evaluation of ketoconazole loaded nanostructured lipid carrier gel for topical deliveryRanpise, HA; Gujar, KN; Pawar, SC; Awasthi, R; Dua, K; Mathure, D; Madan, JR
2020-05Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.Madan, JR; Khobaragade, S; Dua, K; Awasthi, R
2017-01-01Hydrogel based drug delivery systems: A review with special emphasis on challenges associated with decontamination of hydrogels and biomaterialsKikuchi, IS; Galante, RSC; Dua, K; Malipeddi, VR; Awasthi, R; Ghisleni, DDM; de Jesus Andreoli Pinto, T
2021Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives.Usman, MB; Bhardwaj, S; Roychoudhury, S; Kumar, D; Alexiou, A; Kumar, P; Ambasta, RK; Prasher, P; Shukla, S; Upadhye, V; Khan, FA; Awasthi, R; Shastri, MD; Singh, SK; Gupta, G; Chellappan, DK; Dua, K; Jha, SK; Ruokolainen, J; Kesari, KK; Ojha, S; Jha, NK
2018-01-01Improving dissolution profile of poorly water-soluble drug using non-ordered mesoporous silicaMadan, JR; Patil, S; Mathure, D; Bahirat, SP; Awasthi, R; Dua, K
2017-07Improving the solubility of nevirapine using A hydrotropy and mixed hydrotropy based solid dispersion approach.Madan, JR; Kamate, VJ; Dua, K; Awasthi, R
2019-02-01Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systemsDua, K; Malyla, V; Singhvi, G; Wadhwa, R; Krishna, RV; Shukla, SD; Shastri, MD; Chellappan, DK; Maurya, PK; Satija, S; Mehta, M; Gulati, M; Hansbro, N; Collet, T; Awasthi, R; Gupta, G; Hsu, A; Hansbro, PM
2018-03-01Matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of bacteria isolated from pharmaceutical clean roomsAndrade, LDO; Awasthi, R; Dua, K; Andreoli Pinto, TDJ
2020-04Molecular mechanisms of action of naringenin in chronic airway diseasesChin, LH; Hon, CM; Chellappan, DK; Chellian, J; Madheswaran, T; Zeeshan, F; Awasthi, R; Aljabali, AAA; Tambuwala, MM; Dureja, H; Negi, P; Kapoor, DN; Goyal, R; Paudel, KR; Satija, S; Gupta, G; Hsu, A; Wark, P; Mehta, M; Wadhwa, R; Hansbro, PM; Dua, K
2024Monoclonal antibodies and antibody-drug conjugates as emerging therapeutics for breast cancer treatment.Saini, S; Gulati, N; Awasthi, R; Arora, V; Singh, S; Kumar, S; Gupta, G; Dua, K; Pahwa, R; Dureja, H
2018-01Nanoparticles in Cancer Treatment: Opportunities and Obstacles.Awasthi, R; Roseblade, A; Hansbro, PM; Rathbone, MJ; Dua, K; Bebawy, M